Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis

BACKGROUND: Patients with first-episode psychosis or early-phase schizophrenia are susceptible to olanzapine-associated weight gain and cardiometabolic dysregulation. This meta-analysis characterized weight and metabolic effects observed during olanzapine treatment in randomized clinical trials in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Correll, Christoph U, Højlund, Mikkel, Graham, Christine, Todtenkopf, Mark S, McDonnell, David, Simmons, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388390/
https://www.ncbi.nlm.nih.gov/pubmed/37326421
http://dx.doi.org/10.1093/ijnp/pyad029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388390/
https://www.ncbi.nlm.nih.gov/pubmed/37326421
http://dx.doi.org/10.1093/ijnp/pyad029

Ejemplares similares